A detailed history of Ameritas Investment Partners, Inc. transactions in Innoviva, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,422 shares of INVA stock, worth $93,854. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,422
Previous 5,422 -0.0%
Holding current value
$93,854
Previous $88,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $10,670 - $12,152
-741 Reduced 12.02%
5,422 $88,000
Q3 2023

Nov 13, 2023

BUY
$12.37 - $13.89 $17,528 - $19,682
1,417 Added 29.86%
6,163 $80,000
Q2 2022

Aug 12, 2022

BUY
$14.32 - $19.88 $20,363 - $28,269
1,422 Added 42.78%
4,746 $70,000
Q3 2021

Nov 15, 2021

SELL
$13.06 - $17.24 $21,392 - $28,239
-1,638 Reduced 33.01%
3,324 $56,000
Q2 2021

Aug 06, 2021

SELL
$11.45 - $13.96 $8,931 - $10,888
-780 Reduced 13.58%
4,962 $67,000
Q2 2018

Aug 13, 2018

SELL
$13.44 - $17.59 $11,141 - $14,582
-829 Reduced 12.62%
5,742 $79,000
Q1 2018

May 15, 2018

SELL
$13.8 - $16.99 $10,446 - $12,861
-757 Reduced 10.33%
6,571 $110,000
Q2 2017

Aug 15, 2017

BUY
N/A
7,328
7,328 $93,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.21B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.